Traws Pharma, Inc. (NASDAQ: TRAW)
$5.0950
+0.1250 ( +2.52% ) 0.3K
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.
Market Data
Open
$5.0950
Previous close
$4.9700
Volume
0.3K
Market cap
$15.04M
Day range
$4.9700 - $5.1780
52 week range
$4.4400 - $24.7500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| ars | Annual reports | 1 | Oct 23, 2024 |
| def | Proxies and info statements | 4 | Oct 11, 2024 |
| 8-k | 8K-related | 13 | Sep 27, 2024 |
| 3 | Insider transactions | 1 | Sep 23, 2024 |
| 8-k | 8K-related | 16 | Sep 17, 2024 |
| 4 | Insider transactions | 1 | Sep 17, 2024 |
| 3 | Insider transactions | 2 | Sep 17, 2024 |
| 8-k | 8K-related | 13 | Aug 23, 2024 |
| nt | Quarterly Reports | 1 | Aug 15, 2024 |
| 8-k | 8K-related | 14 | Aug 15, 2024 |